Have a feature idea you'd love to see implemented?
Let us know!
ANNX Annexon Inc
Price (delayed)
$5.17
Market cap
$551.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.04
Enterprise value
$500.12M
Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on
Highlights
Annexon's EPS has increased by 43% YoY and by 15% QoQ
Annexon's debt has decreased by 6% YoY
The equity has surged by 111% year-on-year but it has declined by 8% since the previous quarter
Annexon's quick ratio has soared by 76% YoY but it has decreased by 21% from the previous quarter
Key stats
What are the main financial stats of ANNX
Market
Valuations
Earnings
Shares outstanding
106.59M
Market cap
$551.09M
Enterprise value
$500.12M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.65
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$117.5M
EBITDA
-$114.1M
Free cash flow
-$105.48M
Per share
Balance sheet
Liquidity
EPS
-$1.04
Free cash flow per share
-$0.75
Book value per share
$3.14
Revenue per share
$0
TBVPS
$2.71
Total assets
$378.78M
Total liabilities
$47.22M
Debt
$29.61M
Equity
$331.56M
Working capital
$324.25M
Debt to equity
0.09
Current ratio
17.18
Quick ratio
17.02
Net debt/EBITDA
0.45
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-33.9%
Return on equity
-39%
Return on invested capital
-57.2%
Return on capital employed
-32.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ANNX stock price
How has the Annexon stock price performed over time
Intraday
0.19%
1 week
-18.33%
1 month
-30.88%
1 year
104.35%
YTD
13.88%
QTD
-12.67%
Financial performance
How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$131.6M
Net income
-$117.5M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 17% YoY but it fell by 2% QoQ
The company's operating income rose by 13% YoY but it fell by 3.7% QoQ
Growth
What is Annexon's growth rate over time
Valuation
What is Annexon stock price valuation
P/E
N/A
P/B
1.65
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 43% YoY and by 15% QoQ
The equity has surged by 111% year-on-year but it has declined by 8% since the previous quarter
The P/B is 3.5% lower than the 5-year quarterly average of 1.7 but 2.5% higher than the last 4 quarters average of 1.6
Efficiency
How efficient is Annexon business performance
The return on invested capital has grown by 49% year-on-year and by 26% since the previous quarter
The ROE is up by 45% year-on-year and by 13% since the previous quarter
ANNX's ROA is up by 40% YoY and by 11% QoQ
Dividends
What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ANNX.
Financial health
How did Annexon financials performed over time
ANNX's total assets has surged by 86% year-on-year but it is down by 7% since the previous quarter
Annexon's quick ratio has soared by 76% YoY but it has decreased by 21% from the previous quarter
Annexon's debt is 91% less than its equity
The equity has surged by 111% year-on-year but it has declined by 8% since the previous quarter
The debt to equity has dropped by 55% year-on-year but it has grown by 13% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.